Philadelphia College of Osteopathic Medicine

DigitalCommons@PCOM
PCOM Physician Assistant Studies Student
Scholarship

Student Dissertations, Theses and Papers

2018

Does Cognitive Behavioral Therapy (CBT) reduce
symptoms of Attention Deficit Hyperactivity
Disorder (ADHD) in patients older than 12 years
old who are diagnosed with ADHD?
Rebecca Ruby
Philadelphia College of Osteopathic Medicine

Follow this and additional works at: https://digitalcommons.pcom.edu/pa_systematic_reviews
Part of the Medicine and Health Sciences Commons
Recommended Citation
Ruby, Rebecca, "Does Cognitive Behavioral Therapy (CBT) reduce symptoms of Attention Deficit Hyperactivity Disorder (ADHD)
in patients older than 12 years old who are diagnosed with ADHD?" (2018). PCOM Physician Assistant Studies Student Scholarship.
316.
https://digitalcommons.pcom.edu/pa_systematic_reviews/316

This Selective Evidence-Based Medicine Review is brought to you for free and open access by the Student Dissertations, Theses and Papers at
DigitalCommons@PCOM. It has been accepted for inclusion in PCOM Physician Assistant Studies Student Scholarship by an authorized
administrator of DigitalCommons@PCOM. For more information, please contact library@pcom.edu.

Does Cognitive Behavioral Therapy (CBT) reduce symptoms of
Attention Deficit Hyperactivity Disorder (ADHD) in patients older
than 12 years old who are diagnosed with ADHD?

Rebecca Ruby, PA-S
A SELECTIVE EVIDENCE BASED MEDICINE REVIEW
In Partial Fulfillment of the Requirements For
The Degree of Masters of Science
In
Health Sciences – Physician Assistant
Department of Physician Assistant Studies
Philadelphia College of Osteopathic Medicine
Philadelphia, Pennsylvania
December 15, 2017

Abstract
Objective: The objective of this selective EBM review is to determine whether or not “Does
cognitive therapy reduce symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in
patients older than 12 years old who are diagnosed with ADHD?”
Study Design: Systematic review of three randomized controlled trials (RCTs) published in
peer-reviewed journals in 2016, all English language
Data Sources: Three randomized controlled trials were found using PubMed.
Outcomes Measured: ADHD symptoms and patients’ response to cognitive therapy were
measured by patients, parents of patients, and independent evaluators with Disruptive Behavior
Disorder rating scales that included four scales of the Diagnostic and Statistical Manual for
Mental Disorders 4th edition including (1) ADHD Inattention, (2) ADHD
Hyperactivity/impulsivity, (3) Oppositional Defiant Disorder, and (4) Conduct Disorder.
Results: Boyer et al found no significant differences between groups receiving PML and SFT;
instead, they found that patients with more ADHD symptoms benefited more from PML while
patients with less ADHD symptoms benefited more from SFT. Spirch et al found a statistically
significant reduction in parent-rated, patient-rated ADHD symptoms scores and evaluator-rated
CGI scores for participants who received cognitive behavior therapy as opposed to the waitlisted
group. Likewise, Young et al also found a statistically significant and precise reduction and
difference in ADHD symptoms scores between an experimental group receiving CBT and an
experimental group continuing with TAU.
Conclusions: All three Randomized Controlled Trials indicate that CBT is effective in treatment
of ADHD in patients >12 years old by reducing symptoms of impulsivity, hyperactivity, and
inattention as outline in the DSM-IV criteria.
Key Words: cognitive therapy, behavioral therapy, Attention Deficit Hyperactivity Disorder
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Introduction
Attention Deficit Hyperactivity Disorder (ADHD) is a neurocognitive disorder that
presents during childhood development and is associated with symptoms of impulsivity,
inattention, and hyperactivity.1 ADHD is common, affecting 7-8% of children and 2.5% of
adults.1 Furthermore, 65% of patients diagnosed with ADHD during childhood will continue to
meet the criteria for diagnosis through adolescent life.2 ADHD is often comorbid with other
psychiatric and mental disorders, leading to impairment in social, academic, and occupational
settings.3 The cost of ADHD in the United States ranges between $143 billion-$266 billion and is
mostly incurred by education and healthcare expenses. The healthcare costs per American patient
0-21 years old can range $621-$2,270 annually.3 In January 2017, the CDC reported a total visit
rate of 105 out of 1000 persons in one year.4 A Physician Assistant could be directly involved in
the care for a patient with ADHD, as it is a common condition among patients.
ADHD is categorized based on the symptoms a patient most commonly experiences.
Typically, it is thought that features of hyperactivity and impulsivity are manifested together so
patients exhibit and experience feelings of inner restlessness, impatience, or the desire to be “on
the go”.5 Patients with ADHD that is predominantly inattentive will be disorganized, distracted,
or have difficulty focusing.5 In either instance, ADHD is a disease that has the potential to impair
a patient’s functional ability to carry out advanced Activities of Daily Living (ADL). It is known
that ADHD is related to multi-gene mutations and common genetic disorders such as fragile X,
Turner, and Klinefelter syndromes. Though it is often associated with genetic abnormalities, the
exact etiology of the disease is unknown and often considered to be multifactorial.1
Currently, Cognitive Behavioral Therapy (CBT) is the first line treatment for ADHD
because of the conservative means to control symptoms. Often, this diagnosis is made during

Ruby, Effects of CBT on ADHD

2

childhood, so there is a desire to initially attempt modalities other than pharmacologic measures
such as environmental modification and behavioral training.1 As patients grow older, they could
still be affected by similar ADHD symptoms they experienced as a child, and it is important to
study the effects of CBT in an older population. Supplemental pharmacologic therapies include
stimulant medications such as methylphenidate and mixed amphetamine.1 Other alternative
medications include clonidine, guanfacine, and atomoxetins.1 While there are medical treatment
modalities for ADHD, this paper evaluates three randomized controlled trials comparing the
efficacy of CBT as opposed to pharmacotherapy.
Objective
The objective of this selective EBM review is to determine whether or not “Does
Cognitive Behavioral Therapy (CBT) reduce symptoms of Attention Deficit Hyperactivity
Disorder (ADHD) in patients older than 12 years old who are diagnosed with ADHD?”
Methods
Three Randomized Controlled Trials (RCTs), including male and female participants
greater than 12 years old who were diagnosed with ADHD, were selected for this study. Patients
included in the participant pool were required to be previously diagnosed with ADHD by a
primary care provider using criteria found in Diagnostic and Statistical Manual of Mental
Disorders (DSM). During the course of the three trials, participants had the potential to be
selected for CBT so that ADHD-related symptoms and patient function could be monitored. The
basis of this review is to understand if CBT can reduce symptoms of ADHD in adolescents and
adults. CBT is the primary intervention used in all three studies, and therapy programs were
designed by the authors of each study. Areas of focus included planning, problem solving,
reasoning, rehabilitation, and functional impairment reduction. In order to measure the effects of
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therapy, parent-interviews, patient-interviews, and independent evaluators were utilized to
quantify and qualify results. For this review, the outcomes measured were compared with pretrial assessments of each participant’s symptom-related and function-related scores and further
compared to control groups. Patient outcomes were also measured against control groups,
comprised of participants who were receiving different kinds of CBT, their Treatment as Usual
(TAU), or no intervention for ADHD-related symptoms. Patient outcomes were measured based
on DSM-IV criteria scales for ADHD inattention, ADHD hyperactivity/impulsivity,
Oppositional Defiant Disorder, and Conduct Disorder. In addition, scaled criteria for factors
related to function and ADLs were differentiated in subscales including ADHD symptoms,
emotional control, antisocial behavior, and social functioning.
Each study evaluated in this review was a RCT found in the PubMed database by
searching key-words such as cognitive therapy and Attention Deficit Hyperactivity Disorder. All
studies were published in the English language in peer-review journal articles in 2016. The
author completed all research for this review and selected articles based on relevance to the topic
and if the outcomes measures were patient-oriented. In order for these studies to be applicable to
this review, inclusion criteria included RCTs studying patient-oriented outcomes after receiving
CBT for ADHD. Studies were excluded from the review if they contained criteria such as
participants under 12 years old, patients with suicidal ideation, patients with organic mental
disability or autism spectrum disorders. Statistical means by which studies were analyzed include
F, ωp2, p, NNT, Coef. (β), and a study-developed method called QUINT.

Ruby, Effects of CBT on ADHD
Table 1: Demographics & Characteristics of Included Studies
Study
Type # Pts Age
Inclusion
Exclusion
(years) Criteria
Criteria
2
Boyer , RCT 159 12-17 -adolescents 12- -autism spectrum
2016
17 years old
disorder
-attend
-depression with
secondary
suicidal ideation
school
-familial crisis
-diagnosis with -Crohn’s
ADHD with
-addiction
DSM-IV criteria
-IQ >80
Spirch6, RCT 46
14-18 -adolescents 14- -comorbid
2016
18 years old
disorders
-ADHD with
-suicidality
CGI >3
-conduct
-on stable dose disorder
of FDA
-active substance
approved
abuse or
medications for dependence
ADHD
-mental disorder
-no change in
-mental
dose for at least retardation
2 months
-pervasive
developmental
disorder
-history of CBT
for ADHD
7
Young , RCT 95
>18
->18 years old -mental illness
2016
-diagnosis of
-suicidal ideation
ADHD
-eating disorder
-self-reported
-drug abuse
stability on
-intellectual
prescribed
impairment
ADHD
medication for
>1 month

4

W/D Interventions
44

Planning focused
cognitive therapy
(PML) &
Solution focused
cognitive therapy
(SFT)

10

Therapy modules
including:
Psycho-education
& organized
planning,
distractibility,
adaptive
thinking,
procrastination,
parent-adolescent
sessions, parentonly sessions,
relapse
prevention

39

Revision of
Reasoning and
Rehabilitation
pro social
competence
training program

Outcomes Measured
The outcomes measured in the selected studies were based on subjective scores of ADHD
symptoms from the perspectives of patients, parents, and third party independent evaluators and
were centered on patient-oriented outcomes.
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Boyer et al measured ADHD symptoms from four scores of the Disruptive Behavior
Disorder (DBD) rating scale, which included (1) ADHD Inattention, (2) ADHD
Hyperactivity/impulsivity, (3) Oppositional Defiant Disorder, and (4) Conduct Disorder, based
on DSM-IV criteria.2 In this study, planning problems were evaluated using the Behavior Rating
Inventory of Executive Functioning and the Planning/Organizing Scale. Outcomes were
measured via parent-reporting at a pre-test period (one week before intervention), a post-test
period (one week after intervention), and a maintenance period (three months after intervention).
Spirch et al measured outcomes using the results of an independent evaluator ADHD
severity rating scale based on DSM-IV criteria for ADHD-symptoms.6 Scores ranged from 0-3; a
score of zero indicated that the symptom was not present while three indicated that the symptom
was most severe. Spirch et al also used an independent evaluator Clinical Global Impression
(CGI) scale which analyzed the severity of the patient’s symptoms ranging from 1 (indicating not
ill) to 7 (indicating extremely ill). Evaluations were made to identify a patient’s baseline before
treatment, a post-treatment period (four months after treatment) and a maintenance-period (eight
months after treatment).
Young et al utilized a 32 item participant-reported inventory called RATE-S, which
encompassed 4 subscales including (1) ADHD symptoms, (2) emotional control, (3) antisocial
behavior, and (4) social functioning.7 Items were reported on an 8-point scale; a score of zero
indicated “not at all” while a score of eight indicated “most of the time”. Young et al also
utilized the CGI scale to quantify the severity of patients’ ADHD symptoms and related
impairment. The CGI scale was conducted by independent evaluators who were blind to the
population. Analysis was conducted at the participant’s baseline before intervention was
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initiated, immediately after treatment was completed as a post-intervention assessment, and a
follow up score (three months after treatment was ended).
Results
QUINT is a method of statistical analysis Boyer et al devised to understand the
interaction and trajectories of two subgroups – those that received Plan My Life (PML) CBT and
those that received Solution Focused Treatment (SFT) CBT.2 QUINT is a means to evaluate the
qualitative outcomes of a total population’s division into optimal subgroups.2 QUINT analysis
was achieved by separating patients based on pre-test symptom scores and cross-analyzing data
to better predict what would best benefit patient outcomes. Using QUINT trajectories, Boyer et
al found that there was no qualitative treatment-subgroup interaction between the pre-test to
post-test periods.2 Though, QUINT analysis did find that there was a qualitative treatmentsubgroup interaction present during the period between the post-test to 3-month follow up
period.
The final analysis of QUINT is shown in Table 2 and revealed that participants who
began the trial with better symptom-related scores (DBD <24.82) were more likely to benefit
from SFT over PML treatment methods with a moderate effect size shown by d=0.34. The study
shows that patients with less ADHD symptoms had an improvement of symptom scores by 2.98
points when assigned to SFT over PML. Conversely, patients who began with a worse symptomrelated score (DBD >24.82) were more likely to have better responses to the PML treatment than
the SFT treatment with a moderate effect size shown by d=-0.37. The trial shows that patients
with more ADHD symptoms had an improvement of symptom scores by 3.29 points when
assigned to PML over SFT.
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Table 2: Results of QUINT Analysis Showing Optimal Trajectories of Population Subgroups
Parent-rated ADHD
QUINT-projected Score improvement from
Cohen’s d
pretest score (DBD)
benefit
preferential program
<24.82 Less symptoms
SFT
2.98
0.34
>24.82 More symptoms PML
3.29
-0.37
Even though the initial QUINT analysis showed that there would be beneficial responses
to CBT for participants based on pre-test ADHD symptom scores, ad hoc analysis of the data
shows that there was actually no statistically significant differences between groups in response
to treatments, as shown in Table 3.2 Statistical data analysis revealed that there was little
precision about the outcomes of the data set, exhibited by a p=-0.177 for pre to post test results,
and p=0.311 for post-test to follow up treatment outcomes. Both ωp2 of 0.006 and 0.000 show a
small effect size, which means that the responsiveness to treatment was not in strong association
with specific treatment modalities and the difference in response between groups was minimal.
Table 3: Precision and Effect Size of Pre-test to Post-test and Post-test to Follow-up Periods
Time of Evaluation
F
p
ωp 2
Pre-test to Post-test
(1,144) = 1.84
-0.177
0.006
Post-test to Follow up
(1,114) = 1.03
0.311
0.000
Spirch et al held a trial that randomized 46 total participants into a group of 24
participants who would receive CBT at the start of the study and another group of 22 patients
who would be placed on a wait list and have treatment delayed for four months after the start of
the study.6 The study followed a cross-over design in which participants were evaluated within
their randomly assigned group after the intervention was applied. An intent-to-treat analysis was
conducted using a linear mixed model and included all available data from those who did or did
not complete the trial.
Spirch et al found that there was no significant difference between CGI scores of both
groups at baseline, shown in Table 4. A reduction of symptoms, shown by the mean in Table 4
occurs in all groups after the initiation of CBT. This is seen by a reduction of mean score of 4.55
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at four months post-trial to a mean score of 3.20 mean score at the eight months follow up for the
waitlisted group. In the experimental group, there is a reduction in mean score from baseline to
four months post-trial, and again to eight months post-trial, comprising an overall mean score
reduction of 4.75 to 3.71. These results were found to be statistically significant and precise,
given the CI and p values reported of 1.17 (1.39, 0.94) and <0.0001, respectively.6
Table 4: Outcomes of CGI for waitlist (control) and CBT groups
Wait List
CBT
Mean + SD
Mean + SD
Baseline
Post-trial
(4 months)
Follow up
(8 months)

Baseline

4.64 + 0.85

Baseline 4.75 + 0.68

Waitlist

4.55 + 0.80

CBT

3.71 + 0.85

CBT

3.20 + 0.86

CBT

3.71 + 0.96

95% CI

p value

1.17
(1.39, 0.94)

<0.0001

Parent and adolescent reported scores are shown in Table 5 and mirror the trends seen
with CGI scores: a statistically significant reduction in symptoms after the initiation of CBT in
both the experimental and control groups.6 The reductions shown in Table 5 are validated by the
strong correlation and precision of the CI of 10.93 (12.93, 8.93) and p value of <0.0001.

Adolescent ratings

Parent ratings

Table 5: Outcomes of parent-rated scores and adolescent-rated scores for waitlist (control) and
CBT (experimental) groups
Wait List
CBT
Mean + SD
Mean + SD
95% CI
p value
28.05
25.30
Baseline
Baseline
Baseline
+ 9.57
+ 9.17
Post-trial
24.18
16.76
10.93
Waitlist
CBT
<0.0001
(4 months)
+ 8.23
+ 10.40 (12.93, 8.93)
Follow up
12.82
13.71
CBT
CBT
(8 months)
+ 6.51
+ 9.65
14.41
16.46
Baseline
Baseline
Baseline
+ 8.35
+ 10.90
Post-trial
13.86
11.95
5.34
Waitlist
CBT
<0.0001
(4 months)
+ 8.12
+ 8.89
(7.21, 3.28)
Follow up
7.42
9.71
CBT
CBT
(8 months)
+ 3.71
+ 7.21
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Absolute Benefit Increase and Numbers Needed to Treat (NNT) were also used to
analyze the efficacy of the trial’s outcomes.6 This trial reveals an especially effective NNT,
which was calculated to be 4. Though, the study provided data that showed only a 32% increase
in benefit as a result of the intervention.
Young et al conducted a study with 95 participants (N=90) that were randomized into a
control group containing 47 participants (N=47) and an experimental group of 48 participants
(N=48).7 All participants of the controlled trial were analyzed in the group they were randomly
assigned. An intent-to-treat analysis was conducted. Data was analyzed using a linear mixed
model while controlling for age as a variable.
Outcomes of ADHD-related symptoms and CGI scores at baseline showed no statistically
significant difference in scores between the experimental group that received CBT and the
control group who maintained treatment as usual, as shown in Table 6. Table 6 also shows a
steady reduction in both RATE-S and CGI scores for the experimental group depicted by an
overall reduction in mean score of 41.76 to 29.28 for RATE-S and 3.96 to 3.14 for CGI. Though,
the patients who resumed TAU showed no or minimal reduction in these scores throughout the
progression of the trial, as seen by comparing RATE-S score at baseline (40.39) to follow up
(38.66) or CGI score at baseline (3.91) to follow up (3.80).
Table 6: Outcomes measured by RATE-S Scores and Clinical Global Impression Scores at
baseline, end of treatment, and follow up
CBT (Mean + SD)
TAU (Mean + SD)
Baseline
End of
Follow
Baseline
End of
Follow
Mean
Treatment Mean up Mean
mean
Treatment Mean up Mean
41.76
34.30
29.28
40.39
38.77
38.66
RATE-S
+ 11.05 + 10.30
+ 11.47 + 11.56
+ 11.56
+ 11.93
3.96
3.03
3.14
3.91
3.79
3.80
CGI
+ 0.81
+ 1.05
+ 0.79
+ 1.10
+ 0.77
+ 0.96
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Young et al compared baseline scores to the end-of-treatment scores and also made
comparisons between end-of-treatment scores and the follow-up scores.7 Both comparisons show
a reduction in ADHD symptoms for participants receiving CBT. Table 7 indicates the highly
significant reducing trends with highly precise estimates for RATE-S outcomes in patients, as
noted by the significant p values of <0.05. The criteria of ADHD-symptoms and social
functioning, noted by large Coef (β) calculations of -5.4 and -5.31, respectively shows that these
variables strongly influenced the outcome of improving ADHD symptoms and ADLs of patients
with ADHD. The largest effect sizes were noted in the ADHD symptoms and antisocial
behavior, noted by the large effect sizes, d= 0.55 and 0.50, respectively. Overall, Young et al
found that participants who received CBT showed a greater reduction in symptoms and
functional scores than those participants who were in the TAU group.7
Table 7: Estimated treatment effect for Rate-S symptoms
RATE-S Outcome

Coef (β)

Standard error

P value

95% CI

Effect Size (d)

ADHD symptoms
Social functioning

-5.64
-5.31

1.58
1.48

<0.001
<0.001

(-8.75, -2.53)
(-8.21, -2.41)

0.55
0.41

Patients who had previously received a formal diagnosis of ADHD met with evaluators
and cognitive behavioral therapy coaches in an outpatient setting. No study reported any adverse
events associated with receiving CBT.
Discussion
Cognitive Behavioral Therapy is an emerging treatment for psychological and
psychosocial disorders in the United States. As a supplemental treatment, there is no harm or
contraindications to engaging in CBT. CBT is a treatment modality that combines the techniques
of cognitive and developmental therapies and theories of human behavior.7 In the literature, CBT
has been utilized to aid in the treatment of multiple psychological and neurocognitive disorders.
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For example, CBT has been studied to be a supplemental treatment of borderline personality
disorder, schizophrenia, obsessive compulsive disorder, post-traumatic stress disorder, eating
disorders, and addictive disorders.7 Because CBT is a developing modality of treatment, there is
much that needs to be studied in relation to CBT and efficacy. The selected studies were limited
mostly by the ability to blind participants from treatment groups. Patients and parents were
aware of the which participants received CBT and represented a potential source for bias in
reported results. Though a relatively new method of treatment, CBT is recommended as first-line
for treatment of psychosocial disorders, especially ADHD.
Conclusion
The results of these studies shows that CBT is effective in reducing the symptoms of
ADHD and aids in the functional improvement of ADLs. Though, further studies should be
conducted to overcome some of the barriers that these trials faced. For example, these studies did
not address the differences in which pre-trial ADHD symptoms predominated in patients and
thus did not consider how this would factor into response to CBT. Further studies could assess
the response to CBT in patients with ADHD and separate data for 3 patient populations where
ADHD symptoms are predominantly (1) hyperactive, (2) inattentive, or (3) impulsive. The study
could then measure how these three ADHD-subgroups respond to treatment and ensure that
cognitive behavioral therapy could be universally utilized as treatment. In addition, these studies
utilized patient and parent-based scores to determine the efficacy of the treatments, even though
patients and parents were not blind to treatment. This factor is a potential source for bias in the
study; thus, possibly influencing the outcome measurements of the effectiveness of the therapy.
Further research should better utilize independent evaluators as the means for analysis.
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